T50.902 Poisoning by unspecified drugs, medicaments and biological substances, intentional self-harm

Name of the Condition

• Poisoning by unspecified drugs, medicaments and biological substances, intentional self-harm (ICD-10 Code: T50.902)

Summary

This condition involves intentional self-harm through exposure to unspecified drugs, medications, or biological substances. The term "unspecified" indicates that the exact substance causing the poisoning is not identified or documented at the time of diagnosis. Intentional self-harm implies the event was deliberate, distinguishing it from accidental or therapeutic exposures.

Causes

Intentional self-harm by unspecified substances may result from deliberate ingestion, inhalation, or contact with medications or biological agents. The exact cause is often unclear when the substance is not identified, particularly in cases where the patient cannot or will not disclose details. This may occur due to lack of documentation, unknown substances, or incomplete testing.

Risk Factors

• History of mental health conditions (e.g., depression, anxiety)
• Prior self-harm or suicide attempts
• Access to medications or biological substances
• Social or environmental stressors
• Substance use disorders

Symptoms

Symptoms can vary widely depending on the substances involved but may include:

• Nausea, vomiting, or abdominal pain
• Altered mental status (e.g., confusion, drowsiness)
• Respiratory distress or depression
• Cardiovascular instability (e.g., hypotension, arrhythmias)
• Neurological symptoms (e.g., seizures, coma)

Diagnosis

Diagnosis is based on clinical presentation, patient history (when available), and exclusion of other causes. Laboratory testing may be performed to identify substances, though the "unspecified" designation applies when results are inconclusive or unavailable. Documentation of intentional self-harm is critical for accurate coding.

Treatment Options

Treatment focuses on stabilizing the patient, managing symptoms, and addressing the underlying intent. This may include decontamination, supportive care (e.g., airway management, fluid resuscitation), and psychiatric evaluation. Specific antidotes are used if the substance is identified.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning, timeliness of treatment, and underlying mental health status. Follow-up care often involves psychiatric support, safety planning, and monitoring for recurrence. Long-term outcomes vary based on individual circumstances.

Complications

Potential complications include organ damage (e.g., liver, kidney), respiratory failure, cardiac arrest, or permanent neurological impairment. Psychological sequelae, such as PTSD or ongoing suicidal ideation, may also occur.

Lifestyle & Prevention

Prevention strategies include secure storage of medications, limiting access to harmful substances, and addressing mental health needs. Education on safe medication use and recognizing signs of self-harm is important for at-risk individuals.

When to Seek Professional Help

Seek immediate medical attention if self-harm is suspected or if symptoms of poisoning (e.g., altered consciousness, severe nausea, difficulty breathing) are present. Prompt evaluation is critical for reducing harm and addressing underlying issues.

Tips for Medical Coders

Use T50.902 when documenting intentional self-harm by unspecified drugs, medicaments, or biological substances. Ensure clinical documentation clearly supports the intentional nature of the event and the unspecified substance. If the substance is later identified, coding may be updated, but the initial encounter should reflect available information.